DCGI approves DRDO’s anti-COVID oral drug ‘2-DG’ for emergency use
The Drug Controller General of India (DCGI) has approved the emergency use of DRDO's anti-COVID-19 therapeutic oral drug 2-deoxy-D-glucose (2-DG) ...
The Drug Controller General of India (DCGI) has approved the emergency use of DRDO's anti-COVID-19 therapeutic oral drug 2-deoxy-D-glucose (2-DG) ...
Pfizer’s experimental oral drug to treat COVID-19 at the first sign of illness could be available before the end of ...